A LEAP TO THE CURE

Welcome to the Brand page for “A LEAP TO THE CURE”, which is offered here for Therapeutic pharmaceuticals for the treatment of friedreich's ataxia and other life-threatening and rare diseases;.

Its status is currently believed to be active. Its class is unavailable. “A LEAP TO THE CURE” is believed to be currently owned by “Agilis Biotherapeutics, LLC”.

Owner:
AGILIS BIOTHERAPEUTICS, LLC
Owner Details
Description:
Therapeutic pharmaceuticals for the treatment of Friedreich's ataxia and other life-threatening and rare diseases;
Categories: THERAPEUTIC PHARMACEUTICALS TREATMENT